HC Wainwright & Co. reiterates Buy rating on Armata Pharmaceuticals, $15 price target

HC Wainwright & Co. reiterated their Buy rating on Armata Pharmaceuticals's stock with a price target of $15.00.The price target implies an upside of 257.1% from the Sep 22 close of $4.20.Key takeaways from the analyst noteContinued Government Support: Armata Pharmaceuticals received an additional…